摘要
Despite advancements made in the therapeutic strategies on hepatocellular carcinoma (HCC), the survival rate of HCC patient is not satisfactory enough. Therefore, there is an urgent need for the valuable prognostic biomarkers in HCC therapy. In this study, we aimed to screen hub genes correlated with prognosis of HCC via multiple databases. 117 HCC-related genes were obtained from the intersection of the four databases. We subsequently identify 10 hub genes (JUN, IL10, CD34, MTOR, PTGS2, PTPRC, SELE, CSF1, APOB, MUC1) from PPI network by Cytoscape software analysis. Significant differential expression of hub genes between HCC tissues and adjacent tissues were observed in UALCAN, HCCDB and HPA databases. These hub genes were significantly associated with immune cell infiltrations and immune checkpoints. The hub genes were correlated with clinical parameters and survival probability of HCC patients. 147 potential targeted therapeutic drugs for HCC were identified through the DGIdb database. These hub genes could be used as novel prognostic biomarkers for HCC therapy.
学科与关键词
- Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinomaZhen, Limin; Ning, Gang; Wu, Lina; Zheng, Yongyuan; Yang, Fangji; Chen, Tongtong; Xu, Wenxiong; Liu, Ying; Xie, Chan*; Peng, Liang*Bioscience Reports, 2020, 40: BSR20192593.被引 6
- Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular CarcinomaZhang, Qifan; Xiao, Zhen; Sun, Shibo; Wang, Kai; Qian, Jianping; Cui, Zhonglin; Tao, Tao*; Zhou, Jie*Cancer Management and Research, 2021, 13: 2307-2317.被引 11
- Deciphering essential druggable genes reveals potential immune-inflammatory axis in hepatocellular carcinomaWang, Xiaoren; Cui, Xudong; Wang, Wencan; Sun, Jia; Wang, Yan; Han, Wanru; Xie, Xiaotong; Zhu, Zhu; Zhang, Xijun; Yu, Lei*; Liu, Dabin*Computers in Biology and Medicine, 2023, 167: 107625.
